PenderFund Capital Management Ltd.
Position in RNA — Atrium Therapeutics, Inc.
CIK 1706164
VANCOUVER, A1
Position in RNA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$6,590
+$39 QoQ
Shares Held
490
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#116
of 155 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PenderFund Capital Management Ltd. holds $1,699,256 across 5 Biotechnology names. RNA ranks #3 (0.4% of the industry book) .
All Filings in RNA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,590 | 490 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $6,551 | 490 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||